Loading...
IZOZ.F logo

Izotropic CorporationOTCPK:IZOZ.F Stock Report

Market Cap US$16.9m
Share Price
US$0.25
My Fair Value
n/a
1Y404.2%
7D-11.5%
Portfolio Value
View

Izotropic Corporation

OTCPK:IZOZ.F Stock Report

Market Cap: US$16.9m

Izotropic (IZOZ.F) Stock Overview

A research and development company, develops diagnostic products for detecting breast cancers. More details

IZOZ.F fundamental analysis
Snowflake Score
Valuation0/6
Future Growth5/6
Past Performance0/6
Financial Health2/6
Dividends0/6

IZOZ.F Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Izotropic Corporation Competitors

Price History & Performance

Summary of share price highs, lows and changes for Izotropic
Historical stock prices
Current Share PriceCA$0.25
52 Week HighCA$0.37
52 Week LowCA$0.019
Beta2.42
1 Month Change-1.03%
3 Month Change16.18%
1 Year Change404.24%
3 Year Change-55.77%
5 Year Change-71.02%
Change since IPO-8.32%

Recent News & Updates

Recent updates

Shareholder Returns

IZOZ.FUS Medical EquipmentUS Market
7D-11.5%-1.1%-3.7%
1Y404.2%0.9%11.0%

Return vs Industry: IZOZ.F exceeded the US Medical Equipment industry which returned 0.4% over the past year.

Return vs Market: IZOZ.F exceeded the US Market which returned 11.9% over the past year.

Price Volatility

Is IZOZ.F's price volatile compared to industry and market?
IZOZ.F volatility
IZOZ.F Average Weekly Movement11.2%
Medical Equipment Industry Average Movement8.3%
Market Average Movement6.4%
10% most volatile stocks in US Market17.0%
10% least volatile stocks in US Market2.9%

Stable Share Price: IZOZ.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: IZOZ.F's weekly volatility has decreased from 29% to 11% over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
2016n/aBob Thastizocorp.com

Izotropic Corporation, a research and development company, develops diagnostic products for detecting breast cancers. The company develops and commercializes IzoView, a CT diagnostic imaging device with a platform of targeted uses offering high resolution, true 3D dedicated breast imaging with 360-degree image acquisition and can be used with or without injectable contrast. Izotropic Corporation was incorporated in 2016 and is headquartered in Surrey, Canada.

Izotropic Corporation Fundamentals Summary

How do Izotropic's earnings and revenue compare to its market cap?
IZOZ.F fundamental statistics
Market capUS$16.91m
Earnings (TTM)-US$1.65m
Revenue (TTM)n/a
0.0x
P/S Ratio
-10.5x
P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IZOZ.F income statement (TTM)
RevenueCA$0
Cost of RevenueCA$0
Gross ProfitCA$0
Other ExpensesCA$2.31m
Earnings-CA$2.31m

Last Reported Earnings

Jul 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)-0.034
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio-54.5%

How did IZOZ.F perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/18 22:45
End of Day Share Price 2025/11/18 00:00
Earnings2025/07/31
Annual Earnings2025/04/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Izotropic Corporation is covered by 0 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.